Riik: Austraalia
keel: inglise
Allikas: Department of Health (Therapeutic Goods Administration)
amidotrizoate meglumine, Quantity: 660 mg/mL; sodium amidotrizoate, Quantity: 100 mg/mL
Bayer Australia Ltd
Oral Liquid, solution
Excipient Ingredients: disodium edetate; Anise Oil; polysorbate 80; saccharin; purified water
Oral
250mL, 100mL
Medicine Registered
Not scheduled. Not considered by committee
Gastrografin is a contrast medium for examination of the gastrointestinal tract. It can be administered orally and as enema and is primarily indicated in cases in which the use barium sulfate is unsatisfactory, undesirable or contraindicated. Among these are: - suspected partial or complete stenosis - acute haemorrhage - threatening perforation (peptic ulcer, diverticulum) - other acute conditions which are likely to require surgery - after resection of the stomach or the intestine (danger of perforation or leak) - megacolon - visualisation of a foreign body or tumour before endoscopy - visualisation of gastrointestinal fistula. In addition to these conditions Gastrografin can generally be used for the same purposes as barium sulfate with the exception of the visualisation of mucosal diseases. Due to the insufficient coating properties of Gastrografin, barium sulfate should be used for single or double contrast techniques. In combination with barium sulfate, Gastrografin has considerably improved routine inve
Visual Identification: A clear colourless liquid; Container Type: Bottle; Container Material: Glass Type III Coloured; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius
Registered
1991-08-19
GASTROGRAFIN® 1 GASTROGRAFIN® CONSUMER MEDICINE INFORMATION (CMI) SUMMARY The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. 1. WHY AM I GIVEN GASTROGRAFIN? GASTROGRAFIN contains the active ingredients sodium amidotrizoate and amidotrizoate meglumine. GASTROGRAFIN is a contrast agent used during an X-ray examination. For more information, see Section 1. Why am I given GASTROGRAFIN? in the full CMI. 2. WHAT SHOULD I KNOW BEFORE I AM GIVEN GASTROGRAFIN? Do not use if you have ever had an allergic reaction to GASTROGRAFIN or any of the ingredients listed at the end of the CMI. TALK TO YOUR DOCTOR, RADIOGRAPHER OR NURSE IF YOU HAVE ANY OTHER MEDICAL CONDITIONS, TAKE ANY OTHER MEDICINES, OR ARE PREGNANT OR PLAN TO BECOME PREGNANT OR ARE BREASTFEEDING. The X-ray picture is improved if your bowels are emptied. A cleansing of the bowels before you are given GASTROGRAFIN is recommended. Your doctor, radiographer or nurse will advise you on this. It is important that you still drink fluids as normal. For more information, see Section 2. What should I know before I am given GASTROGRAFIN? in the full CMI. 3. WHAT IF I AM TAKING OTHER MEDICINES? Some medicines may interfere with GASTROGRAFIN and affect how it works. A list of these medicines is in Section 3. What if I am taking other medicines? in the full CMI. 4. HOW AM I GIVEN GASTROGRAFIN? GASTROGRAFIN is given different ways depending on your examination. It will be given by either drinking the solution or as an enema by your doctor, radiographer or nurse. More instructions can be found in Section 4. How am I given GASTROGRAFIN? in the full CMI. 5. WHAT SHOULD I KNOW WHILE RECEIVING GASTROGRAFIN? THINGS YOU SHOULD DO Tell your doctor, radiographer or nurse if you: • experience any of the severe symptoms of loss of consciousness or heart attack, increase in heart rate, difficulty breathing, low blood pressure and swelling of the face, lips or tongue leading to severe breathing difficulties a Lugege kogu dokumenti
1 190213 Gastrografin PI AUSTRALIAN PRODUCT INFORMATION GASTROGRAFIN ® Sodium amidotrizoate / Amidotrizoate meglumine Oral Liquid 1. NAME OF THE MEDICINE Sodium amidotrizoate / Amidotrizoate meglumine 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 100 mL gastroenteral solution contains 10 g sodium amidotrizoate and 66 g amidotrizoate meglumine (sodium diatrizoate and meglumine diatrizoate). For the full list of excipients, see Section 6.1 List of excipients. 3. PHARMACEUTICAL FORM Presentation Gastrografin is a clear, faintly yellowish, aqueous, ionic, hypertonic solution. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS This medicinal product is for use by oral or rectal administration only. Gastrografin is a contrast medium for the examination of the gastrointestinal tract. It can be administered orally and as an enema and is primarily indicated in cases in which the use of barium sulfate is unsatisfactory, undesirable or contraindicated. Among these are: - suspected partial or complete stenosis - acute haemorrhage - threatening perforation (peptic ulcer, diverticulum) - other acute conditions which are likely to require surgery - after resection of the stomach or the intestine (danger of perforation or leak) - megacolon - visualisation of a foreign body or tumour before endoscopy - visualisation of gastrointestinal fistula In addition to these conditions Gastrografin can generally be used for the same purposes as barium sulfate with the exception of the visualisation of mucosal diseases. Due to the insufficient coating properties of Gastrografin, barium sulfate should be used for single or double contrast techniques. In combination with barium sulfate, Gastrografin has considerably improved routine investigation of the gastrointestinal tract both from a diagnostic and from an organisational point of view –in the latter case by speeding up the examination. It is unsuitable only for the diagnosis of enteritis. 2 190213 Gastrografin PI Further indications: a) Early diagnosis of a radiologically undetectable pe Lugege kogu dokumenti